Endo News Roundup: Diabetes Prevention and Remission


Three new diabetes-related studies include these highlights: for those at risk of developing diabetes, long-term use of metformin does not worsen cognitive performance; a score from a validated nomogram predicts diabetes remission with either sleeve gastrectomy or gastric bypass surgery; and another scoring system predicts type 2 diabetes mellitus (DM) remission at 1 year following bariatric surgery.References Long-term Metformin Does Not Affect Cognitive Function Luchsinger JA, et al. Metformin, Lifestyle Intervention, and Cognition in the Diabetes Prevention Program Outcomes Study. Diabetes Care 2017 May; dc162376. https://doi.org/10.2337/dc16-2376Score Predicts Best Surgery for Diabetes Remission Aminian A, et al. Individualized Metabolic Surgery Score: Procedure Selection Based on Diabetes Severity. American Surgical Association 2017 Annual Meeting. April 22, 2017; Philadelphia, Pennsylvania. Scientific Session V, Presentation 27.Validation of Bariatric Surgery Score for Type 2 DM Khowaja A, et. al. Predictability Of Diabetes Mellitus Type 2 Remission And Changes In Metabolic Profile After Bariatric Surgery Using Diarem Scoring System. American Association of Clinical Endocrinologists (AACE) 2017 Annual Scientific & Clinical Congress. May 6, 2017; Austin, Texas. Abstract 1158.

Related Videos
Optimizing Diabetes Therapies with New Classifications
Should We Reclassify Diabetes Subtypes?
Roger S. McIntyre, MD: GLP-1 Agonists for Psychiatry?
Daniel Gaudet, MD, PhD | Credit: American College of Cardiology
© 2024 MJH Life Sciences

All rights reserved.